Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: CRVS) | Delayed: 10.57 +0.74 (7.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.83 | 52 Week High | $17.77 | |||
| Open | $10.29 | 52 Week Low | $9.63 | |||
| Day High | $10.59 | P/E | N/A | |||
| Day Low | $9.77 | EPS | $0.00 | |||
| Volume | 1,271,213 | |||||
